Braidwell »

Adlai Nortye Ltd Sponsored shares owned by Braidwell

Quarter-by-quarter ownership of Adlai Nortye Ltd Sponsored (ANL) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Adlai Nortye Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Adlai Nortye Ltd Sponsored held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adlai Nortye Ltd Sponsored by Braidwell

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.1M 795k 11.50

More positions owned by Braidwell

Caris Life Sciences (CAI)
Hinge Health Cl A (HNGE)
Glaukos (GKOS)
Edgewise Therapeutics (EWTX)
Spyre Therapeutics Com New (SYRE)
Irhythm Technologies (IRTC)
Neogenomics Com New (NEO)
Kodiak Sciences (KOD)
Xenon Pharmaceuticals (XENE)
Alphatec Hldgs Note 0.750% 3/1 (Principal)
Monte Rosa Therapeutics (GLUE)
Dianthus Therapeutics (DNTH)
Neurocrine Biosciences (NBIX)
Alphatec Hldgs Com New (ATEC)
Generate Biomedicines Com Shs (GENB)

View all positions for Braidwell

Top funds holding Adlai Nortye Ltd Sponsored

Cormorant Asset Management
VR Adviser
Balyasny Asset Management
Point72 Asset Management
MPM Oncology Impact Management
Perceptive Advisors
Casdin Capital
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Braidwell
Squadron Capital Management
Eventide Asset Management
Superstring Capital Management
Adage Capital Partners GP

View all funds holding Adlai Nortye Ltd Sponsored